FCLCommodities

Fineotex Chemical Limited

Specialty Chemicals · ISIN INE045J01034 · BSE 533333 · NSE EQ · FV ₹1
Last price
₹53
-0.15%today
What this company does

Fineotex Chemical Limited operates in Specialty Chemicals, part of the Commodities sector. It booked ₹377 cr of revenue in its latest quarter (Q1 FY27) and kept 10.2% of sales as profit.

In the report:
66out of 100
Equitytale Health Score
Solid

Healthier than 66% of companies in Commodities, on all six measures of filed financials. Each measure is ranked against the 91–173 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
neutral
RSI (14)
57

At close. Not part of the score.

Profitability & returns76

How much profit it earns on the money it employs

Balance sheet90

How much it owes, and whether earnings cover the interest

Cash quality35

Whether reported profit actually arrives as cash

Growth & consistency82

Whether sales and profit have grown, and how steadily

Valuation10

What today's price implies, against our models or its peers

Governance & risk100

How much of the promoters' stake is pledged, and how much they hold · highest in its sector on what we could measure

Is this company doing well?
not investment advice
Looks broadly healthyPriced in line with peers
Strengths
Makes a profit
Sales up 175% vs last year
Profit up 55% vs last year
Promoters hold 62%
No promoter shares pledged
Strong 17% return on equity
Virtually debt-free
Turns profit into real cash
Watch-outs
None flagged from our data

What if I invest in FCL?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 10% a year, it would become
₹20.15 lakh

The starting rate is a round number, not a view on this company — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest quarter + price
₹53 -0.15%
latest close · 2026-09-17
52-wk low ₹3742 sessions so far52-wk high ₹62
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/E ratio32.3High
LowAverageHigh
P/B ratio6.99High
Below bookModerateHigh
EV / EBITDA22.2High
LowAverageHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity17.4%Strong
WeakFairStrong ▸15%
Return on capital27.2%Strong
WeakFairStrong
Net margin10.2%Decent
ThinDecentStrong
EBITDA margin18.4%Decent
ThinDecentHealthy
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity0.01Comfortable
LowModerateHigh ▸1
Interest cover642.0×Strong
RiskyOkayStrong ▸5×
Current ratio2.77Ample
Tight ◂1HealthyAmple
More figures
Market cap
₹6,171 cr
Book value
₹8
EPS
₹0.41
latest quarter
Net debt
₹-29 cr
more cash than debt
Enterprise value
₹6,142 cr
EBITDA
₹277 cr
annualised
EBIT
₹259 cr
annualised
Operating margin
17.2%
Return on assets
13.2%
Earnings yield
3.09%
P/S
4.10
Sales / share
₹12.9
Tax rate
25.5%
Face value
₹1
Shares
116.5 cr
Working capital
₹363 cr
Current assets
₹568 cr
Current liabilities
₹205 cr
Delivery %
32.3%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-09-17.

Worth vs price · from the FY 2025 report & filings
not investment advice
Hard to value confidentlyLow confidence
The market price is far above what these earnings- and book-based models support — a fast-growing or asset-light business can trade well above them for years, so we won't put a confident number on how overpriced it is.
Models span ₹11₹13, midpoint ₹12

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · Q1 FY27 (consolidated)
Revenue from Operations₹377 cr
Other Income₹10 cr
Total Income₹387 cr
Cost of Materials₹248 cr
Purchases of Stock-in-Trade₹0 cr
Inventory Change (±)₹-5 cr
Employee Benefit Expense₹27 cr
Finance Costs₹10.1 L
Depreciation & Amortisation₹4 cr
Other Expenses₹47 cr
Total Expenses₹322 cr
Profit before Tax₹65 cr
Tax Expense₹17 cr
Net Profit₹48 cr
Net margin on total income12.5%
Where the money goes · Q1 FY27
% of total income
Materials + stock-in-trade₹243 cr62.9%
Employee benefit expense₹27 cr6.9%
Finance costs₹10.1 L0.0%
Depreciation & amortisation₹4 cr1.1%
Other expenses₹47 cr12.3%
Tax expense₹17 cr4.3%
Profit for the period₹48 cr12.5%
Total income ₹387 cradds up to ₹100 ✓
Quarterly results · consolidated (₹ cr)
MetricQ3 FY26Q4 FY26Q1 FY27
Revenue184 cr314 cr377 cr
Total income190 cr323 cr387 cr
Expenses152 cr275 cr322 cr
Profit before tax38 cr48 cr65 cr
Tax8 cr4 cr17 cr
Net profit (owners' share)26 cr32 cr38 cr
Net margin (owners' share, on revenue)14.3%10.1%10.2%
EPS (₹)0.260.380.41
YoY (latest quarter): total income +164.5% · net profit +54.8%
Balance sheet & cash flow · as of Mar 2026
Debt-free
Total assets
₹1,159 cr
Shareholder equity
₹882 cr
parent shareholders
Total debt
₹8 cr
Cash
₹37 cr
Cash flow · H1 FY26
Operating
₹20 cr
Investing
₹-5 cr
Financing
₹-5 cr
Peer comparison
Specialty Chemicals · by market value
CompanyPriceMarket capP/E
Pidilite Industries Limited₹1,552₹1.58 L cr45.3
Gujarat Fluorochemicals Limited₹4,472₹49,190 cr55.4
Navin Fluorine International Limited₹8,220₹42,169 cr43.3
Deepak Nitrite Limited₹1,605₹21,889 cr15.9
Aether Industries Limited₹1,623₹21,543 cr85.1
Atul Limited₹6,134₹18,057 cr18.4
Aarti Industries Limited₹477₹17,287 cr27.9
Fine Organic Industries Limited₹5,202₹15,949 cr28.9
BASF India Limited₹3,602₹15,591 cr11.2
Same industry · latest reported numbers · not a recommendation.
Corporate actions
Dividend yield
1.60%
trailing 12 months
Dividend / share (TTM)
₹0.85
Last dividend
₹0.05
ex 4 Sep 2026
ActionDetailEx-date
Dividend₹0.05 / share4 Sep 2026
Stock splitStock Split From Rs.2/- to Rs.1/-31 Oct 2025
Bonus issue1:431 Oct 2025
Dividend₹0.8 / share3 Oct 2025
Dividend₹0.4 / share12 Sep 2025
Dividend₹0.4 / share18 Feb 2025
Who owns it · 2026-06-30
No pledge
Promoter
62.3%
FII / Foreign
3.2%
DII / Domestic
1.4%
Retail / others
33.2%
Promoter stake down 0.6% over the last 12 quarters.
Smart-money activity
Insider trades
BoughtFineotex Chemical Limited · Promoters4,000 · ₹9.5 L28 Mar 25
BoughtFineotex Chemical Limited · Promoters20,000 · ₹47.3 L6 Mar 25
BoughtSanjay Tibrewala · Promoters40,000 · ₹89.6 L22 Mar 23
Bulk / block deals
short · NSE115 Sep 26
short · NSE8308 Sep 26
short · NSE3.68 L7 Sep 26
Stake changes
DisposalNippon India Mutual Fund→ 3.65%2 Nov 22
BoughtASHISH KACHOLIA→ 0.50% · 5.50 L1 Aug 22
BoughtMr. Sanjay Tribrewala→ 2.96% · 70,00031 Mar 21
What shareholders were asked to approve
4 proposals passed only on promoter votes

A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.

Special shareholder meeting · 25 Oct 2025
See the official result
1
To consider and approve the increase in Authorized Share Capital and consequential Alteration in Capital Clause of the Memorandum of Association
Backed by 100% of shareholders other than promotersneeded 50%
22.18 L votes for, 1,919 against · 0% of mutual funds and other big investors said no
2
To consider and approve the Sub-Division / Split of Equity Shares and consequential Alteration of Capital Clause of Memorandum of Association of the Company
Backed by 100% of shareholders other than promotersneeded 50%
22.18 L votes for, 1,919 against · 0% of mutual funds and other big investors said no
3
To consider and approve the Issue of Bonus Shares
Backed by 100% of shareholders other than promotersneeded 50%
22.18 L votes for, 1,919 against · 0% of mutual funds and other big investors said no

Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.

Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 10 named members
owning 62.3% between them · as of 2026-06-30
SURENDRAKUMAR DEVIPRASAD TIBREWALA52.28%
SANJAY TIBREWALA3.40%
KANAKLATA TIBREWALA2.82%
KAMAL CHEMICALS PVT. LTD.2.54%
PROTON BIOCHEM PVT LTD0.88%
SURENDRA TIBREWALA0.30%
AARTI MITESH JHUNJHUNWALA0.07%
RITU ADITYA GUPTA0.01%
Business done with them
FY2025 · 3 of the group
The company paid ₹2 cr to companies in the promoter group last year — about 0.4% of its ₹533 cr revenue.
Surendra Tibrewala
Paid them for services · EXPENSES
also owns 0.30% of the company
₹1 cr
company paid
Proton Biochem Private Limited
Paid them for services · EXPENSES
also owns 0.88% of the company
₹60 L
company paid
Proton Biochem Private Limited
Bought goods from them · EXPENSES
also owns 0.88% of the company
₹27 L
company paid
Kanaklata Tibrewala
Leases As Lessor · EXPENSES
also owns 2.82% of the company
₹24.4 L
company received
Surendra Tibrewala
Leases As Lessor · EXPENSES
also owns 0.30% of the company
₹10.7 L
company received

The company also transacted with 17 other related parties — subsidiaries, joint ventures, directors and others — that we could not match by name to the promoter list above. Some may still be connected to the family; we only count the ones the filings let us match with certainty.

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

Money it raised, and what it did with it

When a company raises money from investors, it has to say up front what the money is for. The rules then make it report, every three months until the money is gone, how much of each of those things it has actually paid for — so a promise made while asking for the money can be checked afterwards.

₹136 cr raised in Jul 2025 by selling shares to selected investors

As of Mar 2026, the company says it has spent 69% of what it set aside. ICRA Limited watches the spending on the exchange’s behalf.

Working Capital Requirement
41%
of what was set aside
Expansion of Business of the Company
90%
of what was set aside
General Corporate Purpose
30%
of what was set aside

The rupee amounts in this company’s own breakdown don’t add up to the amount it says it raised — a common filing slip, where a table meant to be read in lakhs is entered as whole rupees. Rather than guess which is right, we show only the percentages, which are unaffected.

₹92 cr raised in May 2024 by selling shares to selected investors

As of Mar 2026, the company says it has spent 74% of what it set aside, leaving ₹32 cr still to be spent. ICRA Limited watches the spending on the exchange’s behalf.

Working Capital Requirement
76%
₹17 cr of ₹22 cr
Expansion of Business of the Company
78%
₹56 cr of ₹71 cr
General Corporate Business
63%
₹19 cr of ₹31 cr

Every figure above is taken from the statement the company files with the stock exchange each quarter, for as long as money it has raised remains unspent. The only thing we work out is how much of each stated purpose has been paid for — one number divided by another from the same filing. Whether a plan that changed was a good change is not something a filing can tell you. See the filing

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.